Zantac on sale over counter
Glaxo has won approval for over-the-counter sales of its best-selling drug, Zantac, in Britain. The drug, which relieves the symptoms of heartburn and dyspepsia, will be on sale within the first quarter of this year, marketed through Glaxo's alli ance with Warner Wellcome.
The company is seeking regulatory approval for over-the-counter sales of the drug in other countries, including the US.
Busin
Subscribe to Independent Premium to bookmark this article
Want to bookmark your favourite articles and stories to read or reference later? Start your Independent Premium subscription today.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies